Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 141Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Effexor

PharmaCompass

01

Brand Name : Effexor

Venlafaxine

arrow
2024 ACI Convention
Not Confirmed

02

Brand Name : Effexor

Venlafaxine

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Effexor

arrow
2024 ACI Convention
Not Confirmed

Venlafaxine

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 280

2021 Revenue in Millions : 317

Growth (%) : -12

blank

03

Brand Name : Effexor

Venlafaxine

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Effexor

arrow
2024 ACI Convention
Not Confirmed

Venlafaxine

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 263

2022 Revenue in Millions : 280

Growth (%) : -6

blank

04

Brand Name : Effexor

Venlafaxine

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Effexor

arrow
2024 ACI Convention
Not Confirmed

Venlafaxine

Main Therapeutic Indication : Neuroscience/Mental Health

Currency : USD

2014 Revenue in Millions : -21.80%

2013 Revenue in Millions :

Growth (%) :

blank

05

Brand Name : Effexor

Venlafaxine

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Effexor

arrow
2024 ACI Convention
Not Confirmed

Venlafaxine

Main Therapeutic Indication : Neuroscience and Mental Health

Currency : USD

2015 Revenue in Millions : 344

2014 Revenue in Millions : 288

Growth (%) : -16%

blank

06

Brand Name : Effexor

Venlafaxine

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Effexor

arrow
2024 ACI Convention
Not Confirmed

Venlafaxine

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2016 Revenue in Millions : 278

2015 Revenue in Millions : 288

Growth (%) : -3

blank

07

Brand Name : Effexor

Venlafaxine

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Effexor

arrow
2024 ACI Convention
Not Confirmed

Venlafaxine

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 297

2016 Revenue in Millions : 277

Growth (%) : 7

blank

08

Brand Name : Effexor

Venlafaxine

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Effexor

arrow
2024 ACI Convention
Not Confirmed

Venlafaxine

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 310

2017 Revenue in Millions : 297

Growth (%) : 4%

blank

09

Brand Name : Effexor

Venlafaxine

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Effexor

Country
arrow
2024 ACI Convention
Not Confirmed

Venlafaxine

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 242

2019 Revenue in Millions : 242

Growth (%) : 0

blank